Release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine.
Jingning Li
Advertisement
Jingning Li is a scientist, analytical development, at Novavax Inc.
Articles by Jingning Li
Advertisement
Latest Updated Articles
Release and Stability Testing Programs for a Novel Virus-Like Particle VaccinePublished: October 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
2
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
3
Analytics, Automation, and Quality Driving the Next Era of Drug Development
4
Trends in Formulation eBook October 2025
5
